- Home
- OCGN vs PINE Comparison
OCGN vs PINE Comparison
Compare OCGN & PINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- PINE
- Stock Information
- Founded
- OCGN 2013
- PINE 2019
- Country
- OCGN United States
- PINE United States
- Employees
- OCGN N/A
- PINE N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- PINE Real Estate Investment Trusts
- Sector
- OCGN Health Care
- PINE Real Estate
- Exchange
- OCGN Nasdaq
- PINE Nasdaq
- Market Cap
- OCGN 205.2M
- PINE 219.7M
- IPO Year
- OCGN N/A
- PINE 2019
- Fundamental
- Price
- OCGN $0.84
- PINE $15.43
- Analyst Decision
- OCGN Strong Buy
- PINE Strong Buy
- Analyst Count
- OCGN 3
- PINE 8
- Target Price
- OCGN $6.00
- PINE $19.00
- AVG Volume (30 Days)
- OCGN 4.8M
- PINE 60.5K
- Earning Date
- OCGN 05-09-2025
- PINE 07-17-2025
- Dividend Yield
- OCGN N/A
- PINE 7.43%
- EPS Growth
- OCGN N/A
- PINE N/A
- EPS
- OCGN N/A
- PINE 0.07
- Revenue
- OCGN $4,522,000.00
- PINE $53,967,000.00
- Revenue This Year
- OCGN N/A
- PINE $7.94
- Revenue Next Year
- OCGN N/A
- PINE $2.82
- P/E Ratio
- OCGN N/A
- PINE $206.44
- Revenue Growth
- OCGN N/A
- PINE 14.94
- 52 Week Low
- OCGN $0.52
- PINE $14.51
- 52 Week High
- OCGN $1.98
- PINE $19.42
- Technical
- Relative Strength Index (RSI)
- OCGN 56.85
- PINE 52.44
- Support Level
- OCGN $0.64
- PINE $14.66
- Resistance Level
- OCGN $0.81
- PINE $15.30
- Average True Range (ATR)
- OCGN 0.09
- PINE 0.25
- MACD
- OCGN 0.00
- PINE 0.08
- Stochastic Oscillator
- OCGN 53.30
- PINE 99.36
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About PINE Alpine Income Property Trust Inc.
Alpine Income Property Trust Inc is a real estate investment trust (REIT) that owns and operates a high-quality portfolio of commercial net lease properties in the United States. The company's portfolio predominantly comprises single-tenant retail properties located in or near metropolitan statistical areas, or MSAs. It operates in two business segments: income properties, which derive maximum revenue, and commercial loans and investments.